Physician profile
David Joseph
NPI 1902840614
$3,412.94
in general payments reported to CMS, 2019-2025
10 companies · $976 in 2025
The $976 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $896 · 2020: $227 · 2021: $313 · 2022: $766 · 2024: $235 · 2025: $976.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $804 · Travel and Lodging: $407.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $803.59 |
| Travel and Lodging | $407.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,362.24 | 2019-2025 | Gamma |
| Curvafix, INC. | $616.89 | 2025 | Curvafix Im Implant |
| Globus Medical, INC. | $201.85 | 2025 | Anthem, Autobahn, Anthem |
| Janssen Pharmaceuticals, INC | $94.20 | 2019-2022 | |
| Depuy Synthes Sales INC. | $50.42 | 2024 | Na |
| Suvon Surgical LLC | $24.60 | 2024 | |
| Solventum Corporation | $23.64 | 2025 | V.A.C.Ulta, V.A.C. Veraflo, Prevena |
| Paragon 28, INC. | $21.70 | 2025 | Phantom Fibula Nail |
| Think Surgical, INC. | $9.18 | 2024 | |
| Polynovo North America LLC | $8.22 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Joseph listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.